Cannabis Watch: Cannabis stocks rally anew as $7 billion GW Pharma deal spurs interest in weed and its medical benefits

  • Written by MarketWatch
  • Published in Economics
Cannabis stocks rallied anew on Wednesday, spurred on by news of a $7 billion deal for the first company to win U.S. regulatory approval for a cannabis-based drug, a move that's expected to boost investor interest in the plant and its medical benefits.

Read more from our friends at MarketWatch